Trials / Completed
CompletedNCT00204646
Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
Phase II Study of Neoadjuvant Dose-Intensive Chemotherapy With Adriamycin and Ifosfamide Followed by High-Dose ICE in Locally Advanced Soft Tissue Sarcomas
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Complete resection is still the only curative treatment option in patients with soft tissue sarcoma (STS). Patients with a non-resectable STS have a dismal prognosis even without evidence of metastatic disease. The aim of this trial is to determine whether neoadjuvant dose-intensive chemo-radiotherapy is a feasible and effective approach in patients with non-resectable STS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adriamycin | |
| DRUG | Ifosfamide | |
| DRUG | Etoposide | |
| DRUG | Carboplatin |
Timeline
- Start date
- 1999-02-01
- Completion
- 2006-12-01
- First posted
- 2005-09-20
- Last updated
- 2007-04-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00204646. Inclusion in this directory is not an endorsement.